SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001293971-24-000010
Filing Date
2024-03-26
Accepted
2024-03-26 07:03:37
Documents
15
Period of Report
2024-03-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240324.htm   iXBRL 8-K 38203
2 EX-99.1 exhibit99120240324.htm EX-99.1 33366
6 image_0.jpg GRAPHIC 23715
  Complete submission text file 0001293971-24-000010.txt   239888

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240324.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240324_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240324_pre.xml EX-101.PRE 12516
18 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240324_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 24780874
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)